Riskpilot← Back to searchSign inGet full accessLINDEBERG APOTEK AS
ASActiveOrg 997508920Jerikoveien 3, 1067 OsloRetail sale of pharmaceutical products · NACE 4773Est. 201111 employees
Revenue 2025
NOK 19,6M
-6% vs 2024
EBITDA margin
0.2%
-88% vs 2024
Equity ratio
24.7%
Financial strength
Net profit 2025
NOK -18K
-110% vs 2024
| Revenue | NOK 19,6M | -6% |
| EBITDA | NOK 38K | -88% |
| Net profit | NOK -18K | -110% |
| Total assets | NOK 3,2M | -11% |
| Equity | NOK 792K | -2% |
| Employees | 11 | — |
Legal name
LINDEBERG APOTEK AS
Org number
997508920
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
27. oktober 2011
Share capital
NOK 100 000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Eie og drive apotek, herunder konsulenttjenester innenfor apotekerbransjen og lege- og helserelaterte produkter, samt øvrig virksomhet i tilknytning til dette.
Address
Jerikoveien 3, 1067 Oslo
Phone
+4723177050
Email
lindeberg.oslo@apotek.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 20 770 | 20 195 | 19 148 | 20 863 | 19 619 |
| Staff expenses | −2 362 | −2 330 | −2 373 | −2 379 | −2 762 |
| EBITDA | 279 | 213 | 431 | 302 | 38 |
| Depreciation & amort. | −33 | −90 | −93 | −93 | −93 |
| EBIT | 246 | 123 | 338 | 209 | −55 |
| Net financials | −6 | 2 | −7 | 26 | 34 |
| Profit before tax | 239 | 125 | 331 | 234 | −22 |
| Tax | 53 | 28 | 78 | 52 | −4 |
| Net profit | 186 | 97 | 253 | 182 | −18 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 164 | 3 427 | 3 657 | 3 626 | 3 213 |
| Equity | 1 208 | 1 116 | 1 119 | 810 | 792 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 956 | 2 311 | 2 537 | 2 816 | 2 421 |
| Total debt | 2 956 | 2 311 | 2 537 | 2 816 | 2 421 |
EBITDA margin
0.2%
This company
15.8%
Market median
-99% vs market
20212025
Equity ratio
24.7%
This company
38.2%
Market median
-35% vs market
20212025
Return on equity
-2.2%
This company
18.4%
Market median
-112% vs market
20212025
Net profit margin
-0.1%
This company
8.1%
Market median
-101% vs market
20212025
Asset turnover
6.11×
This company
1.12×
Market median
+446% vs market
20212025
Debt / equity
3.06×
This company
0.62×
Market median
-394% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MI Chief Executive Officer | Chief Executive Officer | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2018 | |
| Chairman | 2018 | |
| Board of Directors | 2018 | |
| Former (1) | ||
| Chairman | 2018 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Maser Management Services As
LINDEBERG APOTEK AS Board members of LINDEBERG APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Margarida Isabel Dos Santos Aveiro | Chief Executive Officer | 0 companies |
| Sigbjørn Astor Alexander Kjeldaas | Board of Directors | 0 companies |
| Liv Johanne Slettevold Kvien | Chairman | 0 companies |
| Liv Johanne Slettevold | Chairman | 0 companies |
| Anja Catharina Kjeldaas Nygaard | Board of Directors | 0 companies |